Evolent Health (EVH) EBITDA US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
EBITDA, bln rub | ? | -65.5 | 23.6 | 90.3 | 7.36 | 46.4 | 132.0 | |
Changes by years, y/y, % | +693% | -136% | +283% | -92% | +530% |
Evolent Health. EBITDA US GAAP, bln rub
Evolent Health. EBITDA US GAAP, changes, %
Evolent Health. EBITDA US GAAP, sum by quarters, bln rub
Evolent Health (EVH) EBITDA US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
EBITDA, bln rub | ? | 27.5 | 29.5 | 26.7 | 35.3 | 40.4 | 132.0 | |
Changes by years, y/y, % | +100% | -223% | -1 657% | -194% | +47% | |||
Changes by quarters, q/q, % | -174% | +7% | -10% | +32% | +14% |